Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2008.18.1891 on November 17 2008

Journal of Clinical Oncology, Vol 27, No 1 (January 1), 2009: pp. 16-23
© 2009 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v27,p2415)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivotto, I. A.
Right arrow Articles by Kennecke, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivotto, I. A.
Right arrow Articles by Kennecke, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Intervals Longer Than 20 Weeks From Breast-Conserving Surgery to Radiation Therapy Are Associated With Inferior Outcome for Women With Early-Stage Breast Cancer Who Are Not Receiving Chemotherapy

Ivo A. Olivotto, Mary L. Lesperance, Pauline T. Truong, Alan Nichol, Tanya Berrang, Scott Tyldesley, François Germain, Caroline Speers, Elaine Wai, Caroline Holloway, Winkle Kwan, Hagen Kennecke

From the British Columbia Cancer Agency–Vancouver Island Centre, Vancouver Centre, Centre for the Southern Interior; and Fraser Valley Centre, Radiation Therapy Program, Systemic Therapy Program, and Breast Cancer Outcomes Unit, University of British Columbia; and the Department of Mathematics and Statistics, University of Victoria, British Columbia, Canada

Corresponding author: Ivo A. Olivotto, BSc, MD, FRCPC, BC Cancer Agency–Vancouver Island Centre, 2410 Lee Ave, Victoria, British Columbia, Canada, V8R 6V5; e-mail: iolivott{at}bccancer.bc.ca

Purpose To determine the interval from breast-conserving surgery (BCS) to radiation therapy (RT) that affects local control or survival.

Patients and Methods The 10-year Kaplan-Meier (KM) local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and breast cancer–specific survival (BCSS) were computed for 6,428 women who had T1 to 2, N0 to 1, M0 breast cancer that was diagnosed in British Columbia between 1989 and 2003, and who were treated with BCS and RT without chemotherapy. Intervals from BCS to RT were grouped by weeks as follows: ≤ 4 (n = 83), greater than 4 to 8 (n = 2,288; reference group); greater than 8 to 12 (n = 2,606); greater than 12 to 16 (n = 961); greater than 16 to 20 (n = 358); and greater than 20 weeks (n = 132). Cox proportional hazards models and matching were used to control for confounding variables.

Results The median follow-up time was 7.5 years. The 10-year KM outcomes were as follows: LRFS, 95.4%; DRFS, 90.5%; and BCSS, 92.5%. Compared with the greater than 4 to 8 weeks group, hazard ratios (HR) were not significantly different for any outcome among patients who were treated up to 20 weeks after BCS. However, LRFS (hazard ratio [HR], 2.00; P = .15), DRFS (HR, 1.86; P = .02) and BCSS (HR, 2.15; P = .009) were inferior for women with BCS-to-RT intervals greater than 20 weeks compared with those greater than 4 to 8 weeks. The matched analysis yielded similar results.

Conclusion Outcomes were statistically similar for BCS-to-RT intervals up to 20 weeks, but they were inferior for intervals beyond 20 weeks. Time can be reasonably allowed for the breast to heal and for patients to consider treatment options, but RT should start within 20 weeks of BCS.

published online ahead of print at www.jco.org on November 17, 2008.

Ivo A. Olivotto has provided expert testimony on the effects of time between surgery and radiation therapy on breast cancer outcomes.

Presented in part at the 30th San Antonio Breast Cancer Symposium, Dec 13-16, 2007, San Antonio, TX.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
T. L. Lash and S. R. Cole
Immortal Person-Time in Studies of Cancer Outcomes
J. Clin. Oncol., August 10, 2009; 27(23): e55 - e56.
[Full Text] [PDF]


Home page
JWatch Oncology and HematologyHome page
Delaying Radiation Therapy After Breast-Conserving Surgery
Journal Watch Oncology and Hematology, February 3, 2009; 2009(203): 2 - 2.
[Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online